Chronic Kidney Disease stage3
24
3
3
11
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
8.3%
2 terminated out of 24 trials
84.6%
-1.9% vs benchmark
13%
3 trials in Phase 3/4
36%
4 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (24)
Renal Denervation in Chronic Kidney Disease - RDN-CKD Study
Feasibility, Safety and Efficacy of a Predominantly Plant-based Diet in an Asian Population With Chronic Kidney Disease
Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
A Pragmatic Approach to CKD Patient Education
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
Evaluation of the Safety and Tolerability of Gemini in Subjects With Stage 3-4 Chronic Kidney Disease.
Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
PR-0164 First in Human Clinical Trial of the PAVmed PortIO Intraosseous Infusion System
Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment
Study of Sulphoraphane in Chronic Kidney Disease
Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease
Effect of Intradialytic Exercises in Chronic Kidney Disease Patients
Evaluation of the Effectiveness of Platelet-based and Microvesicle-based Assays to Predict Thrombotic and Bleeding Risk in Chronic Kidney Disease Patients With Acute Coronary Syndrome
Validation and Evaluation of a Newly Developed Mobile Diet App
Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management
Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3
Application of Wearable Devices to Build a Self-Management Model in Chronic Kidney Disease Patients
Effect of Empagliflozin on Urinary Excretion of Adenosine and Osteocyte Function in Patients With Chronic Kidney Disease
Role of Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous
Pathophysiological Characterization of the Neuromuscular Function of a Population With Multiple Comorbidities Suffering From Chronic Renal Failure in Pre-dialysis.